Company
Edgewise Therapeutics, Inc. (EWTX)
Standardized SEC financial data for Edgewise Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001710072 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-32.1%
Free cash flow
-$144.1M
Current ratio
19.85×
EPS (diluted)
$-1.63
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $15.0M | $32.2M | $54.0M | $90.9M | $127.0M | $151.4M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $104.9M | $15.6M | $22.0M | $86.1M | $41.7M | $61.1M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$14.6M | -$33.5M | -$52.6M | -$91.9M | -$109.0M | -$143.8M |
| Capital expenditures |
Get EWTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/EWTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/EWTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"